心臓ポンプデバイスの市場規模、シェア、動向分析レポート：タイプ別、製品別、最終用途別、地域別、セグメント予測、2025年～2030年

心臓ポンプデバイス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、心臓ポンプデバイスの世界市場規模は2030年までに63億9,000万米ドルに達し、2025年から2030年にかけて13.6%のCAGRで拡大すると推定されています。

冠動脈疾患、虚血性心疾患、その他のCVD疾患の有病率の増加は、心臓ポンプデバイスの需要を押し上げると予測されています。例えば、英国心臓財団（British Heart Foundation）が発表したデータによると、2022年に英国では約760万人が心臓病を患い、毎年約16万人がCVDやその他の心臓関連疾患で死亡しています。さらに、2020年のWHOのデータによると、日本では冠動脈性心疾患により16万3,905人が死亡しており、そのうち脳卒中による死亡は12万1,823人（11.03％）でした。

さらに、疾患啓発のための支援や啓発活動の増加により、市場は成長すると予想されます。例えば、2022年1月、IIT KanpurのThe School of Medical Research and Technologyは、課題ベースのプログラムであるHridyantraを開始しました。その目的は、末期心不全（HF）患者のために左心室補助装置（LVAD）と呼ばれる高度な人工心臓を作ることです。Hridyantraは、HF患者が利用できる治療法を改善することを目的としています。このプログラムにより、HF患者が利用できる治療選択肢が大幅に改善され、市場成長の原動力となることが期待されます。

心臓ポンプデバイス市場のレポートハイライト

• タイプ別では、植え込み型心臓ポンプデバイス分野が2024年に市場の69.1%と最大の売上シェアを占めました。これは、血液の送り出しを補助し、移植への橋渡しやHF患者の永続的な治療オプションとして機能するためです。
• 製品別では、補助人工心臓（VAD）が2024年に68.5％の最大市場シェアを占めました。予測期間中のCAGRは14.8％と最も速いと予測されています。世界のHF有病率の増加により、補助人工心臓の需要は予測期間中に急速に伸びると予測されています。
• 最終用途別では、病院セグメントが2024年に市場を独占しました。
• 北米は、心不全の有病率の高さ、高齢化人口の増加、強固なヘルスケアシステムにより、2024年には52.59％以上の売上高シェアで市場を独占すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 心臓ポンプデバイス市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 心臓ポンプデバイス市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
• 心臓ポンプデバイス市場：パイプライン分析

第4章 心臓ポンプデバイス市場：タイプの推定・動向分析

• タイプセグメントダッシュボード
• 心臓ポンプデバイス市場：タイプ変動分析
• 世界の心臓ポンプデバイス市場規模と動向分析（タイプ別、2018～2030年）
• 埋め込み型心臓ポンプデバイス
• 体外心臓ポンプデバイス

第5章 心臓ポンプデバイス市場：製品の推定・動向分析

• 製品セグメントダッシュボード
• 心臓ポンプデバイス市場：製品変動分析
• 世界の心臓ポンプデバイス市場規模と動向分析（製品別、2018～2030年）
• 心室補助装置（VAD）
  • 左室補助装置（LVAD）
  • 右室補助装置（RVAD）
  • 両心室補助装置（BiVAD）
  • 経皮的心室補助装置（PVAD）
• 大動脈内バルーンポンプ（IABP）
• 体外式膜型人工肺（ECMO）

第6章 心臓ポンプデバイス市場：最終用途の推定・動向分析

• 最終用途セグメントダッシュボード
• 心臓ポンプデバイス市場：最終用途変動分析
• 世界の心臓ポンプデバイス市場規模と動向分析（最終用途別、2018～2030年）
• 病院
• 心臓センター
• 研究機関

第7章 心臓ポンプデバイス市場：地域推定・動向分析

• 地域市場ダッシュボード
• 地域別市場シェア分析、2024年および2030年
• 地域別市場：主なポイント
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
• 企業プロファイル
  • Abbott
  • ABIOMED（Johnson &Johnson Services, Inc.）
  • Getinge
  • LivaNova PLC
  • Berlin Heart
  • Picard Medical, Inc.（SynCardia Systems, LLC）
  • Jarvik Heart, Inc
  • BiVACOR Inc.
  • Leviticus Cardio
  • Teleflex Incorporated

List of Tables

• Table 1 List of abbreviations
• Table 2 Global heart pump device market, by region, 2018 - 2030 (USD Million)
• Table 3 Global heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 4 Global heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 5 Global heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 6 North America heart pump device market, by country, 2018 - 2030 (USD Million)
• Table 7 North America heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 8 North America heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 9 North America heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 10 U.S. heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 11 U.S. heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 12 U.S. heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 13 Canada heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 14 Canada heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 15 Canada heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 16 Mexico heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 17 Mexico heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 18 Mexico heart market, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe heart pump device market, by country, 2018 - 2030 (USD Million)
• Table 20 Europe heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 21 Europe heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 22 Europe heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 23 Germany heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 24 Germany heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 25 Germany heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 26 UK heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 27 UK heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 28 UK heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 29 France heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 30 France heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 31 France heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 32 Italy heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 33 Italy heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 34 Italy heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 35 Spain heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 36 Spain heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 37 Spain heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 38 Denmark heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 39 Denmark heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 40 Denmark heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 41 Sweden heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 42 Sweden heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 43 Sweden heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 44 Norway heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 45 Norway heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 46 Norway heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific heart pump device market, by country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific heart pump Device market, by type, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 51 China heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 52 China heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 53 China heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 54 Japan heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 55 Japan heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 56 Japan heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 57 India heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 58 India heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 59 India heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 60 South Korea heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 61 South Korea heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 62 South Korea heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 63 Australia heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 64 Australia heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 65 Australia heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 66 Thailand heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 67 Thailand heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 68 Thailand heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 69 Latin America heart pump device market, by country, 2018 - 2030 (USD Million)
• Table 70 Latin America heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 71 Latin America heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 72 Latin America heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 73 Brazil heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 74 Brazil heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 75 Brazil heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 76 Argentina heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 77 Argentina heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 78 Argentina heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 79 MEA heart pump device market, by country, 2018 - 2030 (USD Million)
• Table 80 MEA heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 81 MEA heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 82 MEA heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 83 South Africa heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 84 South Africa heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 85 South Africa heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 89 UAE heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 90 UAE heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 91 UAE heart pump device market, by end use, 2018 - 2030 (USD Million)
• Table 92 Kuwait heart pump device market, by type, 2018 - 2030 (USD Million)
• Table 93 Kuwait heart pump device market, by product, 2018 - 2030 (USD Million)
• Table 94 Kuwait heart pump device market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Heart pump device market: market outlook
• Fig. 10 Heart pump device competitive insights
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration and growth prospect mapping
• Fig. 14 Industry value chain analysis
• Fig. 15 Heart pump device market driver impact
• Fig. 16 Heart pump device market restraint impact
• Fig. 17 Heart pump device market strategic initiatives analysis
• Fig. 18 Heart pump device market: type movement analysis
• Fig. 19 Heart pump device market: type outlook and key takeaways
• Fig. 20 Implanted heart pump devices market estimates and forecast, 2018 - 2030
• Fig. 21 Extracorporeal heart pump devices market estimates and forecast, 2018 - 2030
• Fig. 22 Heart pump device market: product movement Analysis
• Fig. 23 Heart pump device market: product outlook and key takeaways
• Fig. 24 Ventricular Assist Devices (VADs) market estimates and forecasts, 2018 - 2030
• Fig. 25 Left Ventricular Assist Devices (LVAD) market estimates and forecasts,2018 - 2030
• Fig. 26 Right Ventricular Assist Devices (RVAD) market estimates and forecasts,2018 - 2030
• Fig. 27 Bi-Ventricular Assist Devices (BiVAD) market estimates and forecasts,2018 - 2030
• Fig. 28 Percutaneous Ventricular Assist Devices (PVAD) market estimates and forecasts,2018 - 2030
• Fig. 29 Intra-Aortic Balloon Pumps (IABPs) market estimates and forecasts,2018 - 2030
• Fig. 30 Extracorporeal Membrane Oxygenation (ECMO) market estimates and forecasts, 2018 - 2030
• Fig. 31 Heart pump device market: end use movement analysis
• Fig. 32 Heart pump device market: end use outlook and key takeaways
• Fig. 33 Hospitals market estimates and forecasts, 2018 - 2030
• Fig. 34 Cardiac centers market estimates and forecasts,2018 - 2030
• Fig. 35 Research institute market estimates and forecasts, 2018 - 2030
• Fig. 36 Global heart pump device market: regional movement analysis
• Fig. 37 Global heart pump device market: regional outlook and key takeaways
• Fig. 38 North America market estimates and forecasts, 2018 - 2030
• Fig. 39 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 40 Canada market estimates and forecasts, 2018 - 2030
• Fig. 41 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 42 Europe market estimates and forecasts, 2018 - 2030
• Fig. 43 UK market estimates and forecasts, 2018 - 2030
• Fig. 44 Germany market estimates and forecasts, 2018 - 2030
• Fig. 45 France market estimates and forecasts, 2018 - 2030
• Fig. 46 Italy market estimates and forecasts, 2018 - 2030
• Fig. 47 Spain market estimates and forecasts, 2018 - 2030
• Fig. 48 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 49 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 50 Norway market estimates and forecasts, 2018 - 2030
• Fig. 51 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 52 China market estimates and forecasts, 2018 - 2030
• Fig. 53 Japan market estimates and forecasts, 2018 - 2030
• Fig. 54 India market estimates and forecasts, 2018 - 2030
• Fig. 55 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 56 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 57 Australia market estimates and forecasts, 2018 - 2030
• Fig. 58 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 59 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 60 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 61 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 62 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 63 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 64 UAE market estimates and forecasts, 2018 - 2030
• Fig. 65 Kuwait market estimates and forecasts, 2018 - 2030

Heart Pump Device Market Growth & Trends:

The global heart pump device market size is estimated to reach USD 6.39 billion by 2030, expanding at a CAGR of 13.6 % from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of coronary artery disease, ischemic heart disease, and other CVD diseases is anticipated to boost the demand for heart pump devices. For instance, according to data published by British Heart Foundation, in 2022, about 7.6 million individuals in the UK live with heart disease, and each year, around 160,000 people die from CVD and other heart-related conditions in the UK. Moreover, according to WHO data in 2020, coronary heart disease caused 163,905 deaths in Japan, with 121,823 or 11.03% of total deaths were caused due to stroke.

Furthermore, the market is anticipated to grow by increasing support and awareness initiatives for disease awareness. For instance, in January 2022, The School of Medical Research and Technology at IIT Kanpur launched Hridyantra, a challenge-based program. Its objective is to create an advanced artificial heart called a Left Ventricular Assist Device (LVAD) for patients with end-stage heart failure (HF). Hridyantra aims to improve the available treatment options for HF patients. This program is expected to significantly improve the treatment options available for patients with HF, thereby driving market growth.

Heart Pump Device Market Report Highlights:

• Based on type, the implanted heart pump devices segment accounted for the largest revenue share of 69.1% of the market in 2024, due to their ability to assist with pumping blood and serve as a bridge to transplantation or a permanent therapy option for HF patients.
• Based on product, ventricular assist devices (VADs) held the largest market share of 68.5 % in 2024. It is estimated to register the fastest CAGR of 14.8% during the forecast period; owing to the increasing prevalence of HF worldwide, the demand for VADs is anticipated to grow rapidly over the forecast period.
• Based on end-use, the hospital segment dominated the market in 2024, attributed to the high number of surgeries performed in hospitals.
• North America is expected to dominate the market with over 52.59% revenue share in 2024 due to the high prevalence of heart failure, growing aging population, and robust healthcare system.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Product
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type Segment
  • 2.2.2. Product Segment
  • 2.2.3. End Use Segment
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Heart Pump Device Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Heart Pump Device Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
• 3.4. Heart Pump Device Market: Pipeline Analysis

Chapter 4. Heart Pump Device Market: Type Estimates & Trend Analysis

• 4.1. Type Segment Dashboard
• 4.2. Heart Pump Device Market: Type Movement Analysis
• 4.3. Global Heart Pump Device Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Implanted Heart Pump Devices
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Extracorporeal Heart Pump Devices
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Heart Pump Device Market: Product Estimates & Trend Analysis

• 5.1. Product Segment Dashboard
• 5.2. Heart Pump Device Market: Product Movement Analysis
• 5.3. Global Heart Pump Device Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 5.4. Ventricular Assist Devices (VADs)
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Left Ventricular Assist Devices (LVAD)
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Right Ventricular Assist Devices (RVAD)
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Bi-Ventricular Assist Devices (BiVAD)
    • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Percutaneous Ventricular Assist Devices (PVAD)
    • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Intra-Aortic Balloon Pumps (IABPs)
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Extracorporeal Membrane Oxygenation (ECMO)
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Heart Pump Device Market: End Use Estimates & Trend Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Heart Pump Device Market: End Use Movement Analysis
• 6.3. Global Heart Pump Device Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Cardiac Centers
  • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Research Institute
  • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Heart Pump Device Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Dashboard
• 7.2. Regional Market Share Analysis, 2024 & 2030
• 7.3. Continuous bioprocessing market by Region: Key Takeaways
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Mexico
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. UK
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. France
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Italy
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Spain
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Norway
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework/ reimbursement structure
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Regulatory framework/ reimbursement structure
    • 7.5.8.3. Competitive scenario
    • 7.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Australia
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Argentina
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework/ reimbursement structure
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework/ reimbursement structure
    • 7.8.4.3. Competitive scenario
    • 7.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. Key company heat map analysis, 2024
• 8.4. Company Profiles
  • 8.4.1. Abbott
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. ABIOMED (Johnson & Johnson Services, Inc.)
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Getinge
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. LivaNova PLC
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Berlin Heart
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Picard Medical, Inc. (SynCardia Systems, LLC)
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Jarvik Heart, Inc
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. BiVACOR Inc.
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Leviticus Cardio
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Teleflex Incorporated
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives